Synthesis, analgesic and anti-inflammatory activities of some new fenamate analogues

Arzneimittel-Forschung/Drug Research

Volumn 58, Issue 9, 2008, Pages 457-463

  Alafeefy, Ahmed M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Analgesics; Anti inflammatories, non steroidal; Fenamate quinazolinyl analogues, in vivo studies, synthesis; Quinazolines

Indexed keywords

2 (2 PHENYL 6 BROMOQUINAZOLIN 4 YLAMINO)BENZOIC ACID; 2 (2 PHENYL 6 CHLOROQUINAZOLIN 4 YLAMINO)BENZOIC ACID; 2 (2 PHENYL 6 IODOQUINAZOLIN 4 YLAMINO)BENZOIC ACID; 5 [2 (6 BROMO 2 PHENYL QUINAZOLIN 4 YLAMINO)PHENYL] 1,3,4 OXADIAZOL 2(3H) ONE; 5 [2 (6 CHLORO 2 PHENYL QUINAZOLIN 4 YLAMINO)PHENYL] 1,3,4 OXADIAZOL 2(3H) ONE; 5 [2 (6 IODO 2 PHENYL QUINAZOLIN 4 YLAMINO)PHENYL] 1,3,4 OXADIAZOL 2(3H) ONE; ACETIC ACID; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CARRAGEENAN; FENAMIC ACID DERIVATIVE; HYDRAZIDE DERIVATIVE; MEFENAMIC ACID; OXADIAZOLE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; MALE; MOUSE; NONHUMAN; PAW EDEMA; RAT; STRUCTURE ACTIVITY RELATION; ULCEROGENESIS; WRITHING TEST;

EID: 53649099835     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296539     Document Type: Article

References (20)

1. Lombardino G. Nonsteroidal Anti-inflammatory Drugs. New York: Wiley Interscience/John Wiley and Sons; 1985.
2. Ferreira SH, Moncada S, Vane JR. Indomethacine and aspirin abolish prostaglandin release from the spleen. Nature (New Biol). 1971;231:237-239.
3. McMahon AD. Observation and experiment with the efficacy of drugs: A warming example from a cohort of non-steroidal anti-inflammatory and ulcer-healing drug users. Am J Epidemiol. 2001;154:557-562.
4. Charlier C, Michaux C. Dual inhibition of cyclooxygenase-2 (COX-2 and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. Eur J Med Chem. 2003;38:645-659.
5. Unangst PC, Conor DT, Centenko WA, Sorenson RJ, Kostlan RK, Sircar JC, et al. Synthesis and biological evaluation of 5-[[3,5-bis-(1,1- dimethylethyl)-4-hydroxyphenyl] methylene]oxazoles, -thiazoles and imidazoles: Novel dual 5-lipoxygenase and cyclooxygenase inhibitors with anti-inflammatory activity. J Med Chem. 1994;37:322-328.
6. Molvi KI, Vasu KK, Yerande SG, Sudarsanam V, Haque N. Synthesis of new tetrasubstituted thiophenes as novel anti-inflammatory agents. Eur J Med Chem. 2007;45:1-10.
7. Dubois RN. The COX-2 story: Is any drug completely "Safe?". Gastroenterology. 2006;130:6-7.
8. Chandrasekharan Ny Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure and expression. Proc Natl Acad Sci. 2002;99:13926-13931.
9. Rocha GM, Michea LF, Petey EM, Kirby M, Xu Y, Feguson DR, et al. Direct toxicity of nonsteroidal anti-inflammatory drugs for renal medullary cells. Natl Acad Sci. 2001;98:5317-5322.
10. Insel PA. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. The Pharmacological Basis of Therapeutics. New York:McGraw-Hill; 1996. p. 617-635.
11. El-Azzouny AA, Maklad YA, Batrsch H, Zaghary WA, Ibrahim WM, et al. Synthesis and pharmacological evaluation of fenamate analogues: 1,3,4-oxadiazol-2-ones and 1,3,4-oxadiazol-2-thiones. Sci Pharm. 2003;71:331-356.
12. Boschelli DH, Connor DT, Bornemeier DA, Dyer RD, Kennedy J A, Kuipers, PJ et al. 1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: In vitro inhibition of cyclooxygenase and 5-lipooxygenase activities. J Med Chem. 1993;36:1802-1810.
13. Lima PC, Lima LM, Da Silva KC, Leda PH, De Miranda AL, Fraga CA, et al. Synthesis and analgesic activity of novel N-acylarylhydrazones and isosteres derived from natural safrole. Eur J Med Chem. 2000;35:187-203.
14. Figueiredo JM, Camara CA, Amarante EG, Miranda AL, Santos F M, Radrigues CR, et al. Design and synthesis of novel potent antinociceptive agents: Methyl-imidazolyl N-acylhydrazone derivatives. Bioorg Med Chem. 2000;8:2243-2248.
15. Mosaad SM, Mohamed KI, Ahmed MA, Abdel-hamide SG. Pak J Biol Sci. 2004;7(7):1263-1268.
16. Ashok K, Shalabh S, Archana KB, Shipra S, Hemant P, Tripti S, et al. Some new 2,3,6-trisubstituted quinazolines as potent anti-inflammatory, analgesic and COX-II inhibitors. Bioorg Med Chem. 2003;15:5293-5299.
17. Furniss BS, Hannaford AJ, Smith PW, Tatchell AR. Vogel's textbook of practical organic chemistry. 5th ed. Singapore: Longman; 1994.
18. Davidson JS. The preparation of 5-(2-aminophenyl)-1,3,4-oxadiazole-2(3H)- one and its rearrangement to 3-amino-2,4(1H, 3H)-quinazolinedione. Monatsh Chem. 1984;115:565-571.
19. Colliner HJ. Evaluation of drug activities. In: Laurence DR, Bacharach A, editors. Pharmacokinetics 1. London: Academic Press; 1964. p. 189-191.
20. Winter CA, Risely EA, Nuss GW. Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. J Pharm Pharmacol. 1963;9:381-383.